Inventor · disambiguated record
Bingliang Chen
Also filed as: CHEN BINGLIANG
17 granted patents·12 pending applications·877 citations·filing 2007–2025
95Inventor score
Files withINNOVENT BIOLOGICS SUZHOU CO LTD8SQUIBB & SONS LLC7BRISTOL MYERS SQUIBB CO6TERRETT JONATHAN A4MEDAREX INC1
Top patents by PatentIndex Score
29 records- 0199US10441655B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2016·Granted Oct 15, 2019·25 cites·22 claims
- 0299US9492539B2Monoclonal antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·119 cites·65 claims
- 0399US9492540B2Methods for treating cancer using anti-PD-1 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·139 cites·79 claims
- 0499US9387247B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Jul 12, 2016·124 cites·45 claims
- 0599US9358289B2Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Jun 7, 2016·137 cites·49 claims
- 0698US9084776B2Methods for treating cancer using anti-PD-1 antibodiesMEDAREX LLC·Filed 2014·Granted Jul 21, 2015·203 cites·9 claims
- 0797US8268970B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2008·Granted Sep 18, 2012·65 cites·7 claims
- 0894US8399623B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Mar 19, 2013·25 cites·7 claims
- 0991US8383779B2Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 26, 2013·12 cites·7 claims
- 1088US8425904B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Apr 23, 2013·9 cites·17 claims
- 1186US11292836B2Anti-CD47 antibodies and uses thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Apr 5, 2022·3 cites·20 claims
- 1286US2023272079A1Monoclonal Antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2023·Application pending·0 cites
- 1384US8496931B2Monoclonal antibodies against stromal derived factor-1 (SDF-1)POGUE SARAH L·Filed 2007·Granted Jul 30, 2013·13 cites·38 claims
- 1480US2025361313A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1579US2020138945A1Monoclonal Antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2019·Application pending·0 cites
- 1677US2024228642A9Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1776US11512131B2Anti-PD-L1 antibody and uses thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Nov 29, 2022·1 cites·37 claims
- 1872US8420084B2Fully human antibodies specific to CADM1TERRETT JONATHAN ALEXANDER·Filed 2010·Granted Apr 16, 2013·2 cites·22 claims
- 1969US2021363267A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2064US11104739B2Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 31, 2021·0 cites·17 claims
- 2160US2013190481A1Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2257US2025002570A1Anti-vegf a and vegf c bispecific antibodies and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2354US2024293457A1Claudin18.2 chimeric antigen receptor and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 2454US2024026019A1Anti-tnfr2 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2550US2011085970A1Anti-b7h4 monoclonal antibody-drug conjugate and methods of useTERRETT JONATHAN A·Filed 2008·Application pending·0 cites
- 2649US2013156788A1Fully human antibodies specific to cadm1MEDAREX INC·Filed 2012·Application pending·0 cites
- 2749US2022112284A1Novel bispecific antibody molecule and bispecific antibody simultaneously binding to pd-l1 and lag-3INNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 2847US11655296B2Anti-CD47 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted May 23, 2023·0 cites·19 claims
- 2947US11498972B2Anti-OX40 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Nov 15, 2022·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Bingliang Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →